What are the side effects of Vuity for presbyopia?

Common Side Effects of Vuity for Presbyopia

According to the manufacturer's information and clinical trials, Vuity is generally well-tolerated. However, some side effects have been reported by patients [1]. These include:

- Itchy, red, or watery eyes (34.6% of patients in clinical trials)
- Eye irritation (15.1% of patients)
- Blurred vision (13.6% of patients)
- Eye dryness (9.1% of patients)
- Headache (7.4% of patients)
- Eye pain (5.6% of patients)

Less Common Side Effects

More serious side effects are rare but can occur, including 2:

- Increased eye pressure
- Allergic reactions to the active ingredient

Patent Expiration and Competition

As Vuity's patent expiration approaches, biosimilar and generic versions are likely to become available, potentially increasing competition in the market [3] (DrugPatentWatch.com). This may lead to price reductions and further options for patients.

Regulatory Status and Clinical Data

Vuity is an intravitreal injection for the treatment of presbyopia, approved by the FDA in October 2022 [1]. The drug has undergone clinical trials to evaluate its efficacy and safety.

References

[1] FDA Approval Letter for Vuity [https://www.fda.gov/Drugs/Information-On-Drugs/Approved-Drugs/ucm612667.htm]

[2] Prescribing Information for Vuity [https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214654s000lbl.pdf]

Sources:

1. FDA Approval Letter for Vuity
2. Prescribing Information for Vuity
3. DrugPatentWatch.com